Maxine is an experienced entrepreneur, company leader and director, having been actively involved in start-up and expansion stage private company development in New Zealand for more than 30 years’ experience.
Maxine is the Executive Director of Cure Kids Ventures (CKV) and was the founding Chief Executive of CKV. Since CKV’s inception in 2008, Maxine has lead investments for CKV into an impressive portfolio of companies with products and services covering medical devices, medications, diagnostics, health information and healthcare delivery systems.
She founded one of New Zealand’s first biotechnology companies, ICPbio, which grew into a significant biotechnology export business as acknowledged by the NZ Biotechnology industry in awarding her a Distinguished New Zealand Biotechnologist Award in 2000. Maxine was also awarded the Bioscience Achievement Award in 2017.
Among numerous influential roles, she has been the founding director of Industry New Zealand (now New Zealand Trade and Enterprise); a director of the Foundation for Research, Science and Technology; Director of Industrial Research Ltd prior to it becoming Callaghan Innovation; Chair of the NZ biotechnology industry organization, NZBIO and represented New Zealand on the APEC Business Advisory Council from 2010 to 2014.
Currently Maxine is on the board of the Maurice Wilkins Centre for Molecular BioDiscovery and a director of a number of private companies.
Maxine was appointed a Companion of the New Zealand Order of Merit for her services to science, particularly biotechnology.
Maxine holds a Master of Science degree in biological sciences from the University of Auckland and is a chartered member of the NZ Institute of Directors.